© 2021 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2021 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
CURE’s myeloma page is a go-to resource for oncology news and updates in the world of myeloma Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in myeloma.
September 23rd 2021, 9:00pm
The prescription of systemic cancer therapies varies based on a patient’s age, comorbidities, cancer stage and other variables, according to recent research.
September 2nd 2021, 9:00pm
The use of convalescent plasma therapy in patients with blood cancers and COVID-19 was associated with an improvement in survival from the infection.
August 19th 2021, 9:00pm
Patients who are immunocompromised, such as patients with blood cancers, may get the boosted immunity needed to reduce their risk for contracting COVID-19 and hospitalization for compilations related to the virus.
July 31st 2021, 12:00am
Fifteen percent of patients with myeloma did not have detectable antibodies two weeks after receiving the COVID-19 vaccine.
July 29th 2021, 12:00pm
Patients with myeloma who are receiving Pepaxto should discuss the potential risks and benefits of continued treatment with the drug.
July 26th 2021, 1:00pm
About 25% of patients with blood cancer did not produce antibodies after being vaccinated against COVID-19.
July 12th 2021, 1:52pm
Darzalex Faspro has received FDA approval for use in combination with pomalidomide and dexamethasone for patients with multiple myeloma who previously received one line of therapy.
July 1st 2021, 1:30pm
Donald Rumsfeld, who died from multiple myeloma, served as secretary of defense under Presidents Gerald R. Ford and George W. Bush.
June 24th 2021, 1:00pm
Recent findings merit further study of the immunosuppressive drug as therapy in patients with multiple myeloma.
June 22nd 2021, 9:00pm
Results from a recent study strongly support a treatment regimen of Darzalex with Revlimid and dexamethasone as a new standard of care for patients with transplant-ineligible newly diagnosed multiple myeloma.
Which Mask is Best for Protecting Patients With Cancer From a COVID-19 Variant?
It’s Not Laziness, It’s Chemo Fatigue
How to Live With Lynch Syndrome: There Is Hope
Treatment Combination Breaks the '5-Year Ceiling' in Metastatic Breast Cancer